| Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer A Bergamaschi, YH Kim, P Wang, T Sørlie, T Hernandez‐Boussard, ... Genes, Chromosomes and Cancer 45 (11), 1033-1040, 2006 | 612 | 2006 |
| Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome A Bergamaschi, E Tagliabue, T Sørlie, B Naume, T Triulzi, R Orlandi, ... The Journal of pathology 214 (3), 357-367, 2008 | 468 | 2008 |
| Regularized multivariate regression for identifying master predictors with application to integrative genomics study of breast cancer J Peng, J Zhu, A Bergamaschi, W Han, DY Noh, JR Pollack, P Wang The annals of applied statistics 4 (1), 53, 2010 | 340 | 2010 |
| Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance A Bergamaschi, BS Katzenellenbogen Oncogene 31 (1), 39-47, 2012 | 236 | 2012 |
| Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer JJ Tao, P Castel, N Radosevic-Robin, M Elkabets, N Auricchio, N Aceto, ... Science signaling 7 (318), ra29-ra29, 2014 | 164 | 2014 |
| hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis A Iervolino, G Santilli, R Trotta, C Guerzoni, V Cesi, A Bergamaschi, ... Molecular and cellular biology 22 (7), 2255-2266, 2002 | 148 | 2002 |
| Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models A Bergamaschi, GO Hjortland, T Triulzi, T Sørlie, H Johnsen, AH Ree, ... Molecular oncology 3 (5-6), 469-482, 2009 | 146 | 2009 |
| The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells A Bergamaschi, Z Madak-Erdogan, YJ Kim, YL Choi, H Lu, ... Breast Cancer Research 16, 1-18, 2014 | 132 | 2014 |
| TGFβ/BMP activate the smooth muscle/bone differentiation programs in mesoangioblasts E Tagliafico, S Brunelli, A Bergamaschi, L De Angelis, R Scardigli, D Galli, ... Journal of cell science 117 (19), 4377-4388, 2004 | 108 | 2004 |
| Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis A Bergamaschi, BL Christensen, BS Katzenellenbogen Breast Cancer Research 13, 1-14, 2011 | 91 | 2011 |
| Focal amplification and oncogene dependency of GAB2 in breast cancer M Bocanegra, A Bergamaschi, YH Kim, MA Miller, AB Rajput, J Kao, ... Oncogene 29 (5), 774-779, 2010 | 87 | 2010 |
| CAMK1D amplification implicated in epithelial–mesenchymal transition in basal-like breast cancer A Bergamaschi, YH Kim, KA Kwei, Y La Choi, M Bocanegra, A Langerød, ... Molecular oncology 2 (4), 327-339, 2008 | 65 | 2008 |
| Highly sensitive quantitative imaging for monitoring single cancer cell growth kinetics and drug response M Mir, A Bergamaschi, BS Katzenellenbogen, G Popescu PLoS One 9 (2), e89000, 2014 | 64 | 2014 |
| Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer SE Holton, A Bergamaschi, BS Katzenellenbogen, R Bhargava PloS one 9 (5), e96878, 2014 | 50 | 2014 |
| Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner A Stanculescu, LA Bembinster, K Borgen, A Bergamaschi, E Wiley, ... Hormones and Cancer 1, 127-135, 2010 | 41 | 2010 |
| 14-3-3ζ as a predictor of early time to recurrence and distant metastasis in hormone receptor-positive and -negative breast cancers. A Bergamaschi, J Frasor, K Borgen, ... Breast Cancer Res Treat. 137 (3), 689-96, 2013 | 36 | 2013 |
| Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters LO Baumbusch, S Myhre, A Langerød, A Bergamaschi, SB Geisler, ... Molecular cancer 5, 1-20, 2006 | 34 | 2006 |
| Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas P Kringen, A Bergamaschi, E Undlien Due, Y Wang, E Tagliabue, ... Biotechniques 39 (5), 755-761, 2005 | 27 | 2005 |
| Relationship between p53 and p27 expression following HER2 signaling P Casalini, MV Iorio, V Berno, A Bergamaschi, ALB Dale, P Gasparini, ... The Breast 16 (6), 597-605, 2007 | 21 | 2007 |
| Gene expression profile of Vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes E Tagliafico, E Tenedini, A Bergamaschi, R Manfredini, R Percudani, ... Cell Death & Differentiation 9 (11), 1185-1195, 2002 | 21 | 2002 |
Tina Hernandez-BoussardAssociate Dean of Research, Professor of Medicine, Stanford UniversityBestätigte E-Mail-Adresse bei stanford.edu
